Early findings highlight its potential ability to: Protect the mucosal lining Reduce inflammation markers Support vascular and tissue recovery But outcomes vary, and human studies are still ongoing
Degraded in GI tract Hepatic first-pass processing Absorption varies by formulation Glutathione Injection Bypasses gastrointestinal processing entirely
Indeed, trefoil peptides have been detected in a number of different types of tumours
At a glance Drug / dulaglutide (Trulicity), a once-weekly subcutaneous GLP-1 receptor agonist Approved dose range / 0.75 mg to 4.5 mg once weekly (subcutaneous injection) Glutathione forms / oral, liposomal oral, sublingual, inhaled, intravenous (IV) Interaction classification / no known pharmacokinetic interaction
Beyond his own Peptual products, readers can ask a prescribing physician about reputable compounding pharmacies in their region, or a telehealth peptide clinic if no local provider has peptide experience